Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Targeted Therapies To Lead New Wave Of Breast Cancer Treatments
http://www.medicalnewstoday.com/articles/113818.php
Rising public awareness about breast cancer and the treatments available has greatly improved revenues in the overall breast cancer therapeutics market. To thrive in this highly competitive market, drug developers must offer drugs that improve survival rates and the quality of life.
One Dose Of IOERT Is Equal To Six Weeks Of Radiation For Breast Cancer
http://www.medicalnewstoday.com/articles/113779.php
Many women with breast cancer may not need six weeks of daily radiation after surgery. This explosive finding was made public at the recent International Society of Intraoperative Radiation Therapy (ISIORT) conference held in Madrid, Spain earlier this month.
Newspapers Examine Developments In Breast Cancer Detection, Surgery
http://www.medicalnewstoday.com/articles/113778.php
<BR />Two newspapers on Tuesday published articles related to breast cancer detection and surgery. Summaries appear below.<BR /><BR />~ <A href="http://www.washingtonpost.com/wp-dyn/content/article/2008/06/30/AR2008063001232.
Peregrine Pharmaceuticals Reports Positive Early Results In Phase II Study Of Bavituximab In Breast Cancer
http://www.medicalnewstoday.com/articles/113736.php
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) reported that its lead product candidate bavituximab achieved the pre-specified Stage 1 primary endpoint in its ongoing Phase II clinical trial in patients with metastatic breast cancer.
----------------------------------------------
** CANCER / ONCOLOGY News **
Advanced Thyroid Cancer Investigational Drug Shows Promise
http://www.medicalnewstoday.com/articles/113890.php
A study by an international team of researchers found that an experimental drug that stops blood vessels that feed tumors from forming was able, in a small number of patients, to slow down the progression of advanced thyroid cancer that has spread to other sites.
Fourth Annual Symposium On Liver-Directed Microsphere Therapy Raises Awareness Of The Latest Advances For Treating Metastatic Liver Tumors
http://www.medicalnewstoday.com/articles/113834.php
More than 170 physicians and health care professionals specializing in the treatment of liver metastases gathered May 2-3 in Chicago for the fourth annual clinical symposium on liver-directed microsphere therapy.
Oncolin Therapeutics Announces The Discovery Of A New More Effective Anti-Cancer Treatment In Experimental Brain Tumor Models
http://www.medicalnewstoday.com/articles/113830.php
Oncolin Therapeutics, Inc., (OTCBB:OCOL) announces that a team of scientists supported by an Oncolin Sponsored Research Agreement (SRA) and lead by Professor Waldemar Priebe from The University of Texas M.
Targeted Therapies To Lead New Wave Of Breast Cancer Treatments
http://www.medicalnewstoday.com/articles/113818.php
Rising public awareness about breast cancer and the treatments available has greatly improved revenues in the overall breast cancer therapeutics market. To thrive in this highly competitive market, drug developers must offer drugs that improve survival rates and the quality of life.
Potential New Ways To Treat Metastatic Cancer Following Discovery Of Gene Mechanism
http://www.medicalnewstoday.com/articles/113804.php
Virginia Commonwealth University and VCU Massey Cancer Center researchers have uncovered how a gene, melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24), induces a bystander effect that kills cancer cells not directly receiving mda-7/IL-24 without harming healthy ones, a discovery that could lead to new therapeutic strategies to fight metastatic disease.
Researcher Using Computers To Hone Cancer Fighting Strategies
http://www.medicalnewstoday.com/articles/113753.php
A Florida State University faculty member who uses computational techniques to evaluate a new class of cancer-killing drugs is attracting worldwide attention from other researchers.Kevin C. Chen, an assistant professor of chemical and biomedical engineering at the Florida A&M University-Florida State University College of Engineering, is using high-powered computers to determine how substances known as recombinant immunotoxins can best be modified in order to attack and kill malignant tumors while doing minimal harm to a patient's healthy cells.
Doctor Knowledge Of Cancer Treatment Options, Costs Key To Advising On Proper Medical Care
http://www.medicalnewstoday.com/articles/113751.php
The growing number of cancer treatment options and their widely varying costs suggest an increased need for oncologists to understand economic issues in cancer care and be able to discuss these issue with their patients, according to a study by researchers at the University of Texas M.
Texas Oncology Urges Texans To 'Save Your Skin:' Outsmart The Sun And Prevent Skin Cancer
http://www.medicalnewstoday.com/articles/113732.php
Now that school is out and the first day of summer is upon us, the cancer care experts at <a href="http://www.TexasOncology.com" target="_blank" rel="nofollow">Texas Oncology </a>remind Texans to "save your skin" by outsmarting the sun when spending time outdoors.
Scientists Predict Three Quarters Of Children With Leukaemia In The UK Will Be Cured
http://www.medicalnewstoday.com/articles/113700.php
Around three-quarters of children diagnosed with <a href="http://info.cancerresearchuk.org/cancerandresearch/cancers/" target="_blank" rel="nofollow">leukaemia</a> will be cured of their disease, according to research published in the <a href="http://www.
Mediterranean Diet Cuts Cancer Risk
http://www.medicalnewstoday.com/articles/113699.php
Adopting just two aspects of the Mediterranean <a href="http://info.cancerresearchuk.org/healthyliving/dietandhealthyeating/" target="_blank" rel="nofollow">diet </a> can cut the risk of developing cancer by 12 per cent - research published in the <a href="http://www.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
VGX Pharmaceuticals Receives FDA Approval Of IND For Novel DNA Vaccine For Cervical Cancer Therapy
http://www.medicalnewstoday.com/articles/113837.php
VGX Pharmaceuticals, Inc. (VGX) announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its DNA vaccine for cervical cancer therapy, VGX-3100.
GSK Does Not Expect FDA Approval Of HPV Vaccine Cervarix Until End Of 2009
http://www.medicalnewstoday.com/articles/113775.php
<BR />GlaxoSmithKline on Monday said it does not expect to receive FDA approval for its human papillomavirus vaccine Cervarix until late 2009, <A href="http://uk.reuters.com/article/hotStocksNewsUS/idUKL3033428020080630" target=_new><CITE>Reuters</CITE></A> reports.
HPV Vaccination - A Missed Opportunity, UK
http://www.medicalnewstoday.com/articles/113705.php
The Royal Society of Health (RSH) welcomes the decision to introduce a national HPV vaccination programme, but with reservations. Responding to the decision taken by the Department of Health last week to use 'Cervarix', one of two HPV vaccines on the market, Professor Richard Parish, RSH Chief Executive said: "The health benefits of vaccination will be considerable, but they could have been much greater.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
Circulating Tumor Cells Can Reveal Genetic Signature Of Dangerous Lung Cancers
http://www.medicalnewstoday.com/articles/113846.php
Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy.
Linking Second-Hand Smoke And Lung Cancer
http://www.medicalnewstoday.com/articles/113713.php
It is a widely accepted notion that second-hand smoke (SHS) is linkedto lung cancer. However, medical professionals and researchers have notreached consensus on the extent of the increase in cancer risk due toSHS.
Smokeless Tobacco Can Also Increase Cancer Risk
http://www.medicalnewstoday.com/articles/113500.php
A review published in <i>The Lancet Oncology</i> findsthat although users of smokeless tobacco products (STPs) likely have alower cancer risk than smokers, they are still increasing their risk ofdeveloping several types of cancer.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Scientists Predict Three Quarters Of Children With Leukaemia In The UK Will Be Cured
http://www.medicalnewstoday.com/articles/113700.php
Around three-quarters of children diagnosed with <a href="http://info.cancerresearchuk.org/cancerandresearch/cancers/" target="_blank" rel="nofollow">leukaemia</a> will be cured of their disease, according to research published in the <a href="http://www.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
No news for this category today.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment